United States was Axcelis Technologies’s largest region in fiscal 2025, bringing in $482.64M of $839.05M (58%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $634.08M | $749.29M | $632.03M | $482.64M | ||||||||||||
| Us | — | — | — | — | ||||||||||||
| Asia Pacific | $246.95M | $335.73M | $347.75M | $306.45M | ||||||||||||
| Segment Geographical Groups Of Countries Group Two | — | — | — | — | ||||||||||||
| Segment Geographical Groups Of Countries Group One | — | — | — | — | ||||||||||||
| Europe | $38.96M | $45.58M | $38.09M | $49.95M | ||||||||||||
| Total | $920.00M | $1.13B | $1.02B | $839.05M |
Axcelis Technologies brought in $839.05M from its three regions in fiscal 2025, the year ended December 31, 2025. That was down 17.6% from $1.02B in fiscal 2024. United States was the largest at $482.64M (57.5%), ahead of Asia Pacific at $306.45M (36.5%) and Europe at $49.95M (6.0%).
Compared with fiscal 2024, Europe grew fastest, up 31.2% to $49.95M, while United States fell the most, down 23.6% to $482.64M. From fiscal 2022 to 2025, combined revenue from these regions fell from $920.00M to $839.05M, a compound annual decline of 3.0%. United States' share of the total fell from 68.9% to 57.5%.
Ion Implantation Systems & Services was Axcelis Technologies’s largest product and service line in fiscal 2025, bringing in $824.10M of $839.05M (98%).
| Product and Service | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ion Implantation Systems & Services | $898.13M | $1.11B | $1.00B | $824.10M | ||||||||||||
| Ion Implantation Systems Services | — | — | — | — | ||||||||||||
| Ion Implantation Systems, Services, & Royalties | — | — | — | — | ||||||||||||
| Ion Implantation Systems Services & Royalties | — | — | — | — | ||||||||||||
| Product | — | — | — | — | ||||||||||||
| Other Systems & Services | $21.87M | $19.33M | $16.82M | $14.95M | ||||||||||||
| Other Products Systems Services & Royalties | — | — | — | — | ||||||||||||
| Services | — | — | — | — | ||||||||||||
| Total | $920.00M | $1.13B | $1.02B | $839.05M |
Axcelis Technologies brought in $839.05M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 17.6% from $1.02B in fiscal 2024. Ion Implantation Systems & Services was the largest at $824.10M (98.2%), ahead of Other Systems & Services at $14.95M (1.8%).
From fiscal 2022 to 2025, combined revenue from these lines fell from $920.00M to $839.05M, a compound annual decline of 3.0%. Ion Implantation Systems & Services' share of the total rose from 97.6% to 98.2%.
Axcelis Technologies (ACLS) reports its revenue by geography and by product and service. In fiscal 2025, United States was its largest region, bringing in $482.64M (57.5% of the total), followed by Asia Pacific at $306.45M (36.5%).
United States was Axcelis Technologies' largest region in fiscal 2025, bringing in $482.64M, or 57.5% of the $839.05M total across its three regions.
Ion Implantation Systems & Services was Axcelis Technologies' largest product and service line in fiscal 2025, bringing in $824.10M, or 98.2% of the $839.05M total across its two product and service lines.
Among Axcelis Technologies' regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 31.2% from $38.09M to $49.95M.
Every figure comes from Axcelis Technologies' annual financial filings, as reported. Each line keeps the name Axcelis Technologies gives it, and years follow its fiscal calendar.
Axcelis Technologies' revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.